Premature deaths after discharge from methadone maintenance: a replication
Related Experiment Video
Updated: May 30, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
George E Woody1, Vince Kane, Kimberly Lewis
1From the VISN 4 Mental Illness, Research Education and Clinical Center (MIRECC) (GEW, VK, KL, RT),, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA; Department of Psychiatry (GEW), Medical School of the University of Pennsylvania, Philadelphia, PA; and Department of Psychiatry (GEW) and Psychology (RT), University of Illinois at Chicago, Chicago, IL.
Objective:
: Examine rate and causes of death among patients discharged from methadone maintenance, relate them to reasons for discharge, and discuss treatment implications.
Method:
: Naturalistic study of deaths and causes of death among 636 opioid-dependent veterans treated with methadone maintenance between January 1, 2000 and August 31, 2002.
Results:
: Among 456 patients who remained on methadone, 31 (6.8%) died (1 overdose, 1 accident, 13 liver problems, 16 other medical). Among 180 discharged patients, 34 (18.8%) died. Reasons for discharge and causes of death were: continuing drug use (N = 52), 11 deaths (4 overdoses, 4 liver problems, 3 other medical); other disciplinary problems (N = 31), 8 deaths (2 suicides, 2 overdoses, 3 other medical, 1 unknown); other reasons (N = 97), 15 deaths (2 suicides, 1 overdose, 1 accident, 7 liver problems, 3 other medical, 1 unknown). Deaths were significantly less (P < 0.05) among patients who remained on methadone than in each category of those discharged. Follow-up interviews of 99 of 146 discharged patients showed problems in drug use, medical, employment, and psychiatric areas, and that only 21% were in treatment.
Conclusions:
: These findings are consistent with a previous study from the same program, and also from other studies, showing that participating in methadone maintenance reduces mortality. Considered in light of the increased mortality among patients discharged for continuing drug use or behavioral problems, these data suggest that premature mortality can be reduced by keeping patients in treatment and/or taking steps to ensure that discharged patients are promptly enrolled in another program.
Related Concept Videos
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Restarting Stalled Replication Forks
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Regression Toward the Mean

